Cepheid
(NASDAQ : CPHD)

( )
CPHD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.96%452.771.0%$898.46m
DHRDanaher Corp. -0.16%216.880.7%$617.91m
MDTMedtronic Plc 1.25%114.730.6%$550.81m
BSXBoston Scientific Corp. 0.09%33.581.0%$541.48m
ABTAbbott Laboratories 1.23%107.720.8%$518.84m
ISRGIntuitive Surgical, Inc. 0.48%729.822.3%$414.22m
DXCMDexCom, Inc. 1.81%318.217.8%$384.51m
BDXBecton, Dickinson & Co. 0.72%229.111.0%$348.04m
ALGNAlign Technology, Inc. 0.38%475.506.4%$319.43m
SYKStryker Corp. -0.30%233.021.3%$293.88m
BAXBaxter International, Inc. 0.86%76.041.8%$280.40m
EWEdwards Lifesciences Corp. 1.22%85.240.4%$229.69m
QDELQuidel Corp. 4.01%188.007.7%$222.25m
IDXXIDEXX Laboratories, Inc. 1.74%454.233.8%$216.71m
AAgilent Technologies, Inc. -0.22%114.101.6%$216.54m

Company Profile

Cepheid is a molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.